• About
    • Leadership Team
    • Board of Directors
  • Our Science
  • RNA Programs
  • Legacy Programs
    • Bentrio Nasal Spray
    • Inner Ear Therapeutics
  • Investors & Media
    • Overview
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Investor FAQs
    • Investor Contact
    • Email Alerts
Altamira Therapeutics logo. Click to return to a homepage.
Altamira Therapeutics logo. Click to return to a homepage.
  • About
    • Leadership Team
    • Board of Directors
  • Our Science
  • RNA Programs
  • Legacy Programs
    • Bentrio Nasal Spray
    • Inner Ear Therapeutics
  • Investors & Media
    • Overview
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Investor FAQs
    • Investor Contact
    • Email Alerts
  • Contact us

Investors & Media

Analyst Coverage

pdf icon

Diamond Equity Research Update Note – December 26, 2024
pdf icon

Diamond Equity Research Update Note – September 25, 2024
pdf icon

Diamond Equity Research Update Note – August 26, 2024
pdf icon

Diamond Equity Research Update Note – June 3, 2024
pdf icon

Diamond Equity Research Initiation Report - April 15, 2024
Altamira Therapeutics logo

© Altamira Therapeutics 2025

  • Imprint
  • Privacy Notice
  • Terms of Use
top arrow icon
Share by: